StockData
ARAYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30

ACCURAY INC

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 27, 2026
$0.14−0.01 (-8.16%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Nov 4, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q4 FY2026
Ended Jun 30, 2026
Aug 19, 2026After market close$100.90M$-0.02–
Q3 FY2026
Ended Mar 31, 2026
May 6, 2026After market close$104.80M$-0.09–
Q2 FY2026
Ended Dec 31, 2025
Feb 4, 2026After market close$102.20M$-0.11–
Q1 FY2026
Ended Sep 30, 2025
Nov 5, 2025After market close$93.90M$-0.18–
Q4 FY2025
Ended Jun 30, 2025
Aug 13, 2025After market close$127.50M$0.01–
Q3 FY2025
Ended Mar 31, 2025
Apr 30, 2025After market close$113.20M$-0.01–
Q2 FY2025
Ended Dec 31, 2024
Feb 5, 2025After market close$116.20M––
Q1 FY2025
Ended Sep 30, 2024
Nov 6, 2024After market close$101.50M$-0.04–
Q4 FY2024
Ended Jun 30, 2024
Aug 14, 2024After market close$134.30M$0.03–
Q3 FY2024
Ended Mar 31, 2024
May 1, 2024After market close$101.10M$-0.06–
Q2 FY2024
Ended Dec 31, 2023
Jan 31, 2024After market close–––

Company guidance

Outlook given with results on Feb 4, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
Adjusted EBITDAnon-GAAPfiscal year 2026$22.00M to $25.00MLowered
Total net revenuefiscal year 2026$440.00M to $450.00MLowered

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Accuray filed with the SEC